Sfoglia per AUTORE
MAGNI M
Collezione AOU San Luigi di Orbassano
Items : 2
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Ricardi U; Tarella C; Ladetto M; Olivieri A; Gini G; Parvis G; Corradini P; Di Nicola M; Matteucci P; Caracciolo D; Passera R; Di Russo A; Magni M; Filippi AR; Bruna R; Devizzi L; Ruella M;
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.
2011
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;